Form 4: TransDigm Director Sells Shares After Option Exercise

Sentiment:

Insider Transaction Report


TransDigm Group Director Kevin Stein executed a pre-planned sale of 700 common shares after exercising stock options.

Summary

  • Kevin M. Stein, a Director of TransDigm Group INC (TDG), engaged in a pre-planned transaction under a Rule 10b5-1 plan.
  • On October 27, 2025, Mr. Stein exercised stock options to acquire 700 shares of common stock at an exercise price of $105.88 per share.
  • Immediately following the exercise, Mr. Stein sold these 700 shares of common stock at an average weighted price of $1,360 per share, with sales occurring in the range of $1,360.0000 to $1,360.9999.
  • The exercise price of the options was adjusted for dividends declared since August 1, 2022.
  • Following these transactions, Mr. Stein's indirect beneficial ownership through the Fortuna Trust decreased from 8,858 to 8,158 shares of common stock.
  • His indirect beneficial ownership of derivative stock options decreased by 700, leaving 72,800 options remaining.

Sentiment

Score: 5

Explanation: A director's pre-planned sale of shares after exercising options is a neutral event. While it reduces direct ownership, the pre-planned nature (10b5-1) mitigates negative sentiment, and the significant profit realized is a positive for the individual.

Positives

  • The transaction was executed under a Rule 10b5-1 plan, indicating a pre-scheduled event rather than a reaction to immediate market conditions.
  • The exercise of stock options by a director demonstrates a realization of value from long-term incentives.
  • The sale price of $1,360 per share is significantly higher than the exercise price of $105.88, indicating a substantial profit for the director.

Negatives

  • A director selling shares, even if pre-planned, reduces their direct equity stake in the company.

Future Outlook

NA

Industry Context

NA

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantKevin Stein granted Power of Attorney to Armani Vadiee, Rachel Quinlan, Lisa Tortora-French, and Adrienne McFaye to execute and file SEC Forms 3, 4, and 5 on his behalf.2025-10-28Streamlines the process for insider transaction reporting for the director, ensuring timely compliance with Section 16(a) of the Securities Exchange Act of 1934.

Related Party Transactions

  • The shares are beneficially owned indirectly through the Fortuna Trust dated June 1, 2018, which is a common arrangement for insider holdings.

Stakeholder Impact

  • Shareholders: The sale of shares by a director, even if pre-planned, slightly reduces insider ownership. However, the pre-planned nature under Rule 10b5-1 suggests it is not based on new, undisclosed negative information.
  • Management: The transaction reflects a director realizing value from their compensation package.

Key Dates

DateDescription
2018-06-01Date of the Fortuna Trust, through which shares are indirectly beneficially owned.
2018-09-30Date stock options became exercisable.
2022-08-01Date from which stock option exercise price adjustments for dividends began.
2025-10-27Date of stock option exercise and subsequent sale of common stock.
2025-10-28Date the Power of Attorney was executed and the Form 4 was signed by attorney-in-fact.
2028-04-25Expiration date of the exercised stock options.

Recommendation

hold

The filing details a routine, pre-planned insider transaction (exercise of options and subsequent sale of shares) by a director. Such transactions, especially when executed under a Rule 10b5-1 plan, are generally not indicative of new material information or a change in the company's fundamental outlook. While the director reduced their direct shareholding, the transaction was pre-scheduled, and a significant profit was realized. This event alone does not provide a strong basis for a 'buy' or 'sell' recommendation, thus a 'hold' is appropriate, pending further fundamental analysis.

Keywords

TransDigm Group, TDG, Kevin Stein, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Director Transaction, 10b5-1 Plan, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.